GB1476016A - Pharmaceutical compositions having anti-tumour activity - Google Patents

Pharmaceutical compositions having anti-tumour activity

Info

Publication number
GB1476016A
GB1476016A GB3206775A GB3206775A GB1476016A GB 1476016 A GB1476016 A GB 1476016A GB 3206775 A GB3206775 A GB 3206775A GB 3206775 A GB3206775 A GB 3206775A GB 1476016 A GB1476016 A GB 1476016A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
tumour activity
lasiokaurin
oridonin
heading
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3206775A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to GB3206775A priority Critical patent/GB1476016A/en
Priority to JP5458076A priority patent/JPS52102434A/ja
Publication of GB1476016A publication Critical patent/GB1476016A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB3206775A 1975-07-31 1975-07-31 Pharmaceutical compositions having anti-tumour activity Expired GB1476016A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB3206775A GB1476016A (en) 1975-07-31 1975-07-31 Pharmaceutical compositions having anti-tumour activity
JP5458076A JPS52102434A (en) 1975-07-31 1976-05-12 Carcinostatic agent consisting oridonin and lasiokaurin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3206775A GB1476016A (en) 1975-07-31 1975-07-31 Pharmaceutical compositions having anti-tumour activity

Publications (1)

Publication Number Publication Date
GB1476016A true GB1476016A (en) 1977-06-10

Family

ID=10332679

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3206775A Expired GB1476016A (en) 1975-07-31 1975-07-31 Pharmaceutical compositions having anti-tumour activity

Country Status (2)

Country Link
JP (1) JPS52102434A (enExample)
GB (1) GB1476016A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075943A3 (en) * 2002-03-06 2004-04-22 Sophie Chen Ph D Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
WO2007132190A1 (en) * 2006-05-11 2007-11-22 Activephyto Technologies Limited Composition for the treatment of resistant cancers comprising oridonin

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075943A3 (en) * 2002-03-06 2004-04-22 Sophie Chen Ph D Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
WO2007132190A1 (en) * 2006-05-11 2007-11-22 Activephyto Technologies Limited Composition for the treatment of resistant cancers comprising oridonin
RU2455002C2 (ru) * 2006-05-11 2012-07-10 Эктивфайто Текнолоджиз Лимитед Композиция, включающая оридонин и предназначенная для лечения резистентных злокачественных опухолей
CN101495108B (zh) * 2006-05-11 2014-10-15 活性植物科技有限公司 用于抗性癌症治疗的包含冬凌草甲素的组合物
US9089546B2 (en) 2006-05-11 2015-07-28 Activephyto Technologies Limited Synergistic compositions consisting essentially of combinations of active agents selected from oridonin, wogonin, and isoliquiritigenin for the prevention of neoplasia

Also Published As

Publication number Publication date
JPS52102434A (en) 1977-08-27
JPS54967B2 (enExample) 1979-01-18

Similar Documents

Publication Publication Date Title
DE2862002D1 (en) Cis-platinum (ii) complexes of 1,2-diamino-cyclohexane and pharmaceutical composition containing them
AU7953675A (en) Pharmaceutical composition containing 2, 6-diisopropylphenol
GB1542848A (en) Anti-mycotic pharmaceutical compositions containing enzymes
CA983854A (en) Pharmaceutical composition containing nitroglycerin
IL65843A (en) Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type
AU497597B2 (en) Hydrocurable oxazolidine containing compositions
AU510696B2 (en) Liquid antiperspirant composition
IL52227A (en) Process for the preparation of 10,19-dihydro-vitamin d derivatives and some novel 10,19-dihydro-1alpha-hydroxy and 1 alpha,25-dihydroxy-vitamin d3 compounds and pharmaceutical compositions containing them
PH13709A (en) Daunorubicin derivatives and pharmaceutical compositions containing same
AU507272B2 (en) Pharmaceutical compositions and compounds
GB1476016A (en) Pharmaceutical compositions having anti-tumour activity
ES483662A1 (es) Un procedimiento para la produccion de una 2-aminoetil-1-fe-nilindolina
AU534564B2 (en) Pharmaceutical compositions containing paracetamol
IE39291L (en) Pharmaceutical compositions containing an enzyme and substrate
AU499139B2 (en) Slow-release composition containing phentolamine
IL52665A0 (en) Novel antibiotic substance its manufacture and pharmaceutical compositions containing it
IL48147A (en) Pharmaceutical compositions containing substituted tetrahydrofuro(3-4-b)furan2,4-diones and some novel compounds of this type
AU441022B2 (en) An improved capsule for containing an article (divisional of 408,028)
JPS5254036A (en) Composition of mouth drug containing trifluormethylphenyl bissbiguanide as tartar preventive agent
NZ180693A (en) 1,2,3,4-tetrahydro-4-oxo(oroxy)-1-naphthylurea derivatives,veterinary compositions containing them and the 1,2,3,4 tetrahydro-4-oxo-1-naphthylamine precursors
CA909264A (en) Compounds and compositions of stabilized perfluoropolyether fluids
NZ180577A (en) Oxazole derivatives and pharmaceutical compositions containing such
CA898117A (en) Composition for the surface-treating of metals
IL44477A0 (en) Pharmaceutical compositions containing pancreatic enzyme
CA1026672A (en) Pharmaceutical composition for the treatment of cancer

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940731